183 related articles for article (PubMed ID: 27100959)
1. Utility of the ACE Inhibitor Captopril in Mitigating Radiation-associated Pulmonary Toxicity in Lung Cancer: Results From NRG Oncology RTOG 0123.
Small W; James JL; Moore TD; Fintel DJ; Lutz ST; Movsas B; Suntharalingam M; Garces YI; Ivker R; Moulder J; Pugh S; Berk LB
Am J Clin Oncol; 2018 Apr; 41(4):396-401. PubMed ID: 27100959
[TBL] [Abstract][Full Text] [Related]
2. Decreased risk of radiation pneumonitis with incidental concurrent use of angiotensin-converting enzyme inhibitors and thoracic radiation therapy.
Kharofa J; Cohen EP; Tomic R; Xiang Q; Gore E
Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):238-43. PubMed ID: 22300564
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin-converting enzyme inhibitors decrease the risk of radiation pneumonitis after stereotactic body radiation therapy.
Harder EM; Park HS; Nath SK; Mancini BR; Decker RH
Pract Radiat Oncol; 2015; 5(6):e643-9. PubMed ID: 26412341
[TBL] [Abstract][Full Text] [Related]
4. A prospective study on radiation pneumonitis following conformal radiation therapy in non-small-cell lung cancer: clinical and dosimetric factors analysis.
Claude L; Pérol D; Ginestet C; Falchero L; Arpin D; Vincent M; Martel I; Hominal S; Cordier JF; Carrie C
Radiother Oncol; 2004 May; 71(2):175-81. PubMed ID: 15110451
[TBL] [Abstract][Full Text] [Related]
5. Toxicity and outcome results of RTOG 9311: a phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma.
Bradley J; Graham MV; Winter K; Purdy JA; Komaki R; Roa WH; Ryu JK; Bosch W; Emami B
Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):318-28. PubMed ID: 15667949
[TBL] [Abstract][Full Text] [Related]
6. First results of a phase I/II dose escalation trial in non-small cell lung cancer using three-dimensional conformal radiotherapy.
Belderbos JS; De Jaeger K; Heemsbergen WD; Seppenwoolde Y; Baas P; Boersma LJ; Lebesque JV
Radiother Oncol; 2003 Feb; 66(2):119-26. PubMed ID: 12648783
[TBL] [Abstract][Full Text] [Related]
7. Mitigation of radiation induced pulmonary vascular injury by delayed treatment with captopril.
Molthen RC; Wu Q; Fish BL; Moulder JE; Jacobs ER; Medhora MM
Respirology; 2012 Nov; 17(8):1261-8. PubMed ID: 22882664
[TBL] [Abstract][Full Text] [Related]
8. A phase III comparison of radiation therapy with or without recombinant beta-interferon for poor-risk patients with locally advanced non-small-cell lung cancer (RTOG 93-04).
Bradley JD; Scott CB; Paris KJ; Demas WF; Machtay M; Komaki R; Movsas B; Rubin P; Sause WT
Int J Radiat Oncol Biol Phys; 2002 Apr; 52(5):1173-9. PubMed ID: 11955727
[TBL] [Abstract][Full Text] [Related]
9. Radiation-induced lung toxicity predictors: Retrospective analysis of 90 patients treated with stereotactic body radiation therapy for stage I non-small-cell lung carcinoma.
Menoux I; Antoni D; Mazzara C; Labani A; Charloux A; Quoix E; Falcoz PE; Truntzer P; Noël G
Cancer Radiother; 2020 Apr; 24(2):120-127. PubMed ID: 32173269
[TBL] [Abstract][Full Text] [Related]
10. Decreased Risk of Radiation Pneumonitis With Coincident Concurrent Use of Angiotensin-converting Enzyme Inhibitors in Patients Receiving Lung Stereotactic Body Radiation Therapy.
Alite F; Balasubramanian N; Adams W; Surucu M; Mescioglu I; Harkenrider MM
Am J Clin Oncol; 2018 Jun; 41(6):576-580. PubMed ID: 27560156
[TBL] [Abstract][Full Text] [Related]
11. Results of a phase I dose-escalation study using three-dimensional conformal radiotherapy in the treatment of inoperable nonsmall cell lung carcinoma.
Rosenzweig KE; Fox JL; Yorke E; Amols H; Jackson A; Rusch V; Kris MG; Ling CC; Leibel SA
Cancer; 2005 May; 103(10):2118-27. PubMed ID: 15830346
[TBL] [Abstract][Full Text] [Related]
12. Phase III study comparing chemotherapy and radiotherapy with preoperative chemotherapy and surgical resection in patients with non-small-cell lung cancer with spread to mediastinal lymph nodes (N2); final report of RTOG 89-01. Radiation Therapy Oncology Group.
Johnstone DW; Byhardt RW; Ettinger D; Scott CB
Int J Radiat Oncol Biol Phys; 2002 Oct; 54(2):365-9. PubMed ID: 12243809
[TBL] [Abstract][Full Text] [Related]
13. TGF-beta1 in serum and induced sputum for predicting radiation pneumonitis in patients with non-small cell lung cancer after radiotherapy.
Wang J; Qiao XY; Lu FH; Zhou ZG; Song YZ; Huo JJ; Liu X
Chin J Cancer; 2010 Mar; 29(3):325-9. PubMed ID: 20193119
[TBL] [Abstract][Full Text] [Related]
14. Three-dimensional conformal radiation therapy for non-small-cell lung cancer: a phase I/II dose escalation clinical trial.
Wu KL; Jiang GL; Liao Y; Qian H; Wang LJ; Fu XL; Zhao S
Int J Radiat Oncol Biol Phys; 2003 Dec; 57(5):1336-44. PubMed ID: 14630271
[TBL] [Abstract][Full Text] [Related]
15. High-dose conformal radiotherapy for treatment of stage IIIA/IIIB non-small-cell lung cancer: technical issues and results of a phase I/II trial.
Rosenman JG; Halle JS; Socinski MA; Deschesne K; Moore DT; Johnson H; Fraser R; Morris DE
Int J Radiat Oncol Biol Phys; 2002 Oct; 54(2):348-56. PubMed ID: 12243807
[TBL] [Abstract][Full Text] [Related]
16. Can serum markers be used to predict acute and late toxicity in patients with lung cancer? Analysis of RTOG 91-03.
Hartsell WF; Scott CB; Dundas GS; Mohiuddin M; Meredith RF; Rubin P; Weigensberg IJ
Am J Clin Oncol; 2007 Aug; 30(4):368-76. PubMed ID: 17762437
[TBL] [Abstract][Full Text] [Related]
17. Long-term Follow-up on NRG Oncology RTOG 0915 (NCCTG N0927): A Randomized Phase 2 Study Comparing 2 Stereotactic Body Radiation Therapy Schedules for Medically Inoperable Patients With Stage I Peripheral Non-Small Cell Lung Cancer.
Videtic GM; Paulus R; Singh AK; Chang JY; Parker W; Olivier KR; Timmerman RD; Komaki RR; Urbanic JJ; Stephans KL; Yom SS; Robinson CG; Belani CP; Iyengar P; Ajlouni MI; Gopaul DD; Gomez Suescun JB; McGarry RC; Choy H; Bradley JD
Int J Radiat Oncol Biol Phys; 2019 Apr; 103(5):1077-1084. PubMed ID: 30513377
[TBL] [Abstract][Full Text] [Related]
18. Prediction of radiation pneumonitis: dose-volume histogram analysis in 62 patients with non-small cell lung cancer after three-dimensional conformal radiotherapy.
Piotrowski T; Matecka-Nowak M; Milecki P
Neoplasma; 2005; 52(1):56-62. PubMed ID: 15739028
[TBL] [Abstract][Full Text] [Related]
19. Control of radiation-induced pneumopathy and lung fibrosis by angiotensin-converting enzyme inhibitors and an angiotensin II type 1 receptor blocker.
Molteni A; Moulder JE; Cohen EF; Ward WF; Fish BL; Taylor JM; Wolfe LF; Brizio-Molteni L; Veno P
Int J Radiat Biol; 2000 Apr; 76(4):523-32. PubMed ID: 10815633
[TBL] [Abstract][Full Text] [Related]
20. Randomized Phase II Study of Preoperative Chemoradiotherapy ± Panitumumab Followed by Consolidation Chemotherapy in Potentially Operable Locally Advanced (Stage IIIa, N2+) Non-Small Cell Lung Cancer: NRG Oncology RTOG 0839.
Edelman MJ; Hu C; Le QT; Donington JS; D'Souza WD; Dicker AP; Loo BW; Gore EM; Videtic GMM; Evans NR; Leach JW; Diehn M; Feigenberg SJ; Chen Y; Paulus R; Bradley JD
J Thorac Oncol; 2017 Sep; 12(9):1413-1420. PubMed ID: 28629896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
